3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
2
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Pancreatic Cancer Metastatic
1
Nasopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Renal Cell Carcinoma (RCC)
1
Advanced Malignant Solid Tumors
1
Advanced Lung Cancer
1
Advanced Breast Cancer
1
Interventions
Nivolumab
21
cabozantinib
12
Specimen Handling
11
Ipilimumab
10
belzutifan
9
pembrolizumab
8
Magnetic Resonance Spectroscopy
8
CTLA-4 Antigen
5
Biopsy
5
Axitinib
5
lenvatinib
4
Sunitinib
4
Immunoglobulin G
3
Disulfides
3
zimberelimab
2
tivozanib
2
relatlimab
2
pazopanib
2
palbociclib
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Radiosurgery
2
Nephrectomy
2
Bevacizumab
2
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
toripalimab
×
30 days
×
Clear all
No trials found.